BRPI0917830A8 - derivados de indol macrocíclicos úteis como inibidores do vírus da hepatite c - Google Patents

derivados de indol macrocíclicos úteis como inibidores do vírus da hepatite c

Info

Publication number
BRPI0917830A8
BRPI0917830A8 BRPI0917830A BRPI0917830A BRPI0917830A8 BR PI0917830 A8 BRPI0917830 A8 BR PI0917830A8 BR PI0917830 A BRPI0917830 A BR PI0917830A BR PI0917830 A BRPI0917830 A BR PI0917830A BR PI0917830 A8 BRPI0917830 A8 BR PI0917830A8
Authority
BR
Brazil
Prior art keywords
hepatitis
indole derivatives
derivatives useful
virus inhibitors
macrocyclic indole
Prior art date
Application number
BRPI0917830A
Other languages
English (en)
Inventor
Abdellah Tahri
David Craig Mc Gowan
Pierre Jean-Marie Bernard Raboisson
Sandrine Marie Helene Vendeville
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Publication of BRPI0917830A2 publication Critical patent/BRPI0917830A2/pt
Publication of BRPI0917830A8 publication Critical patent/BRPI0917830A8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D515/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D515/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0917830A 2008-08-14 2009-08-14 derivados de indol macrocíclicos úteis como inibidores do vírus da hepatite c BRPI0917830A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08162435 2008-08-14
PCT/EP2009/060580 WO2010018233A1 (en) 2008-08-14 2009-08-14 Macrocyclic indole derivatives useful as hepatitis c virus inhibitors

Publications (2)

Publication Number Publication Date
BRPI0917830A2 BRPI0917830A2 (pt) 2015-11-24
BRPI0917830A8 true BRPI0917830A8 (pt) 2016-07-26

Family

ID=40276035

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0917830A BRPI0917830A8 (pt) 2008-08-14 2009-08-14 derivados de indol macrocíclicos úteis como inibidores do vírus da hepatite c

Country Status (12)

Country Link
US (1) US8357687B2 (pt)
EP (1) EP2331554B1 (pt)
CN (1) CN102124012B (pt)
AU (1) AU2009281138B2 (pt)
BR (1) BRPI0917830A8 (pt)
CA (1) CA2733762C (pt)
DK (1) DK2331554T3 (pt)
ES (1) ES2411916T3 (pt)
PL (1) PL2331554T3 (pt)
PT (1) PT2331554E (pt)
RU (1) RU2518471C2 (pt)
WO (1) WO2010018233A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008339917B2 (en) * 2007-12-24 2013-02-07 Tibotec Pharmaceuticals Macrocyclic indoles as hepatitis C virus inhibitors
AU2011305652B2 (en) 2010-09-22 2016-10-20 Janssen Biopharma, Inc. Azido nucleosides and nucleotide analogs
PT4065585T (pt) * 2019-11-25 2025-09-30 Alkermes Inc Compostos macrocíclicos substituídos e métodos de tratamento relacionados
US11760747B2 (en) 2020-12-21 2023-09-19 Alkermes, Inc. Substituted piperidino compounds and related methods of treatment

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6054472A (en) * 1996-04-23 2000-04-25 Vertex Pharmaceuticals, Incorporated Inhibitors of IMPDH enzyme
US5807876A (en) * 1996-04-23 1998-09-15 Vertex Pharmaceuticals Incorporated Inhibitors of IMPDH enzyme
TR199802136T2 (xx) 1996-04-23 2001-06-21 Vertex Pharmaceuticals Incorporated �MPDH enzimi inhibit�rleri olarak �re t�revleri.
ATE244717T1 (de) 1997-03-14 2003-07-15 Vertex Pharma Inhibitoren des impdh-enzyms
ES2405316T3 (es) * 1999-03-19 2013-05-30 Vertex Pharmaceuticals Incorporated Inhibidores de la enzima IMPDH
WO2002019369A1 (en) 2000-08-30 2002-03-07 Matsushita Electric Industrial Co., Ltd. Plasma display unit and production method thereof
CA2431187A1 (en) * 2000-12-08 2002-06-13 Ortho-Mcneil Pharmaceutical, Inc. Macroheterocylic compounds useful as kinase inhibitors
EP2335700A1 (en) 2001-07-25 2011-06-22 Boehringer Ingelheim (Canada) Ltd. Hepatitis C virus polymerase inhibitors with a heterobicylic structure
GB0413087D0 (en) 2004-06-11 2004-07-14 Angeletti P Ist Richerche Bio Therapeutic compounds
AU2006242475B2 (en) * 2005-05-02 2011-07-07 Merck Sharp & Dohme Corp. HCV NS3 protease inhibitors
WO2007092000A1 (en) 2006-02-06 2007-08-16 Bristol-Myers Squibb Company Inhibitors of hcv replication
US7521443B2 (en) * 2006-05-17 2009-04-21 Bristol-Myers Squibb Company Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
WO2008051475A2 (en) * 2006-10-24 2008-05-02 Merck & Co., Inc. Hcv ns3 protease inhibitors
EP2121707B1 (en) 2006-12-20 2012-12-05 Istituto di Ricerche di Biologia Molecolare P. Angeletti S.R.L. Antiviral indoles
JP2010533699A (ja) * 2007-07-17 2010-10-28 イステイチユート・デイ・リチエルケ・デイ・ビオロジア・モレコラーレ・ピ・アンジエレツテイ・エツセ・ピー・アー Ｃ型肝炎感染症の治療のための大環状インドール誘導体

Also Published As

Publication number Publication date
BRPI0917830A2 (pt) 2015-11-24
PL2331554T3 (pl) 2013-08-30
US8357687B2 (en) 2013-01-22
PT2331554E (pt) 2013-05-21
CA2733762A1 (en) 2010-02-18
RU2011109196A (ru) 2012-09-20
WO2010018233A1 (en) 2010-02-18
CN102124012A (zh) 2011-07-13
AU2009281138B2 (en) 2014-03-27
CN102124012B (zh) 2014-07-02
EP2331554B1 (en) 2013-03-06
ES2411916T3 (es) 2013-07-09
EP2331554A1 (en) 2011-06-15
RU2518471C2 (ru) 2014-06-10
DK2331554T3 (da) 2013-05-27
CA2733762C (en) 2017-01-17
AU2009281138A1 (en) 2010-02-18
US20110152279A1 (en) 2011-06-23

Similar Documents

Publication Publication Date Title
BRPI0915887A2 (pt) derivados de indol macrocíclicos úteis como inibidores do vírus da hepatite c
BRPI0821836A2 (pt) Indóis macrocíclicos como inibidores do vírus da hepatite c
BR112012002508A2 (pt) derivados de feniletinila como inibidores de vírus de hepatite c
ES2643164T3 (es) Indol 7-sustituido como inhibidores de Mcl-1
BRPI0908240A2 (pt) inibidores do vírus da hepatite c
BRPI0907733A2 (pt) Inibidores do vírus da hepatite c
BRPI0906625A2 (pt) Derivados de tio-2-amino-quinolina-6-substituída úteis como inibidores da beta-secretase (bace)
BRPI0820085A2 (pt) compostos contendo quinoxalina como inibidores de vírus da hepatite c
BRPI0911444A2 (pt) benzoimidazóis como inibidores de prolil hidroxilase
BRPI1007836A2 (pt) Inibidores do vírus c da hepatite
BRPI1008846A2 (pt) inibidores do vírus da hepatite c
BRPI1013393A2 (pt) inibidores do vírus da hepatite c
BRPI1014084A2 (pt) inibidores do vírus da hepatite c
BRPI0922912A8 (pt) peptídeos de 4-amino-4-oxobutanoil como inibidores de replicação viral
EP2266989A4 (en) HETEROCYCLIC DERIVATIVES
BRPI0923497A2 (pt) derivados de piridazinona
BRPI0915064A2 (pt) derivados de qunoxalinadiona
BRPI0809221A2 (pt) indol carboxamidas como inibidores de ikk2
BRPI1008855A2 (pt) derivados de indol como agentes anticâncer
BRPI0913832A2 (pt) derivados de pirrolopiridinilpirimidin-2-ilamina
BRPI0914942A2 (pt) Compostos de oxindol
IL207684A0 (en) Substituted indole derivatives
BRPI0912234A2 (pt) derivados de salinosporamida como inibidores de proteassomas
PT2513105E (pt) Derivados de 2-arilimidazole como inibidores da enzima pde10a
BR112013002122A2 (pt) derivados hetero-bicíclicos como inibidores de hcv

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: JANSSEN SCIENCES IRELAND UC (IE)

B25A Requested transfer of rights approved

Owner name: JANSSEN SCIENCES IRELAND UC (IE)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements